$782 Million is the total value of First Light Asset Management, LLC's 69 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 16.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MODN | Sell | MODEL N INC | $68,763,000 | +25.7% | 1,960,725 | -0.5% | 8.79% | +6.3% |
| OXFD | Buy | OXFORD IMMUNOTEC GLOBAL PLC | $67,746,000 | +9.5% | 4,081,055 | +9.7% | 8.66% | -7.4% |
| KRMD | Buy | REPRO-MED SYSTEMS INC | $47,134,000 | +66.2% | 7,218,014 | +0.5% | 6.02% | +40.5% |
| NEO | Buy | NEOGENOMICS INC | $39,106,000 | +55.0% | 1,336,949 | +1.3% | 5.00% | +31.0% |
| MYOK | Sell | MYOKARDIA INC | $38,766,000 | +39.2% | 531,884 | -0.4% | 4.96% | +17.7% |
| OMCL | Sell | OMNICELL INC | $37,060,000 | +12.5% | 453,504 | -0.5% | 4.74% | -4.9% |
| ATRC | Buy | ATRICURE INC | $36,174,000 | +31.2% | 1,112,698 | +0.6% | 4.62% | +10.9% |
| INSM | Sell | INSMED INC | $30,890,000 | +35.3% | 1,293,548 | -0.1% | 3.95% | +14.3% |
| HALO | Buy | HALOZYME THERAPEUTICS INC | $30,155,000 | +15.5% | 1,700,782 | +1.1% | 3.85% | -2.3% |
| XENT | Sell | INTERSECT ENT INC | $29,859,000 | +44.3% | 1,199,169 | -1.4% | 3.82% | +22.1% |
| IMMU | Sell | IMMUNOMEDICS INC | $26,349,000 | +58.9% | 1,245,243 | -0.4% | 3.37% | +34.3% |
| HRTX | Sell | HERON THERAPEUTICS INC | $25,407,000 | +25.9% | 1,081,159 | -0.9% | 3.25% | +6.5% |
| PTLA | Buy | PORTOLA PHARMACEUTICALS INC | $24,094,000 | +17.6% | 1,008,957 | +32.0% | 3.08% | -0.6% |
| SPNE | Sell | SEASPINE HOLDINGS CORP | $21,935,000 | -3.0% | 1,826,404 | -1.4% | 2.80% | -18.0% |
| CDXS | Sell | CODEXIS INC | $18,966,000 | +15.4% | 1,186,113 | -1.0% | 2.42% | -2.5% |
| TEVA | Buy | TEVA PHARMACEUTICAL IND | $16,230,000 | +143.4% | 1,656,171 | +70.9% | 2.08% | +105.9% |
| TNDM | Buy | TANDEM DIABETES CARE INC | $16,010,000 | +99.1% | 268,574 | +97.0% | 2.05% | +68.3% |
| SIBN | Buy | SI-BONE INC | $14,730,000 | +29.0% | 685,131 | +6.1% | 1.88% | +9.1% |
| IONS | Sell | IONIS PHARMACEUTICALS INC | $14,721,000 | -24.3% | 243,691 | -24.9% | 1.88% | -36.0% |
| VAPO | Buy | VAPOTHERM INC | $13,948,000 | +43.9% | 1,147,010 | +12.0% | 1.78% | +21.6% |
| XNCR | Sell | XENCOR INC | $11,481,000 | +1.5% | 333,855 | -0.5% | 1.47% | -14.2% |
| VCYT | Sell | VERACYTE INC | $11,421,000 | +15.8% | 409,077 | -0.4% | 1.46% | -2.1% |
| MYL | Buy | MYLAN N V | $10,709,000 | +187.6% | 532,783 | +183.0% | 1.37% | +143.2% |
| TRHC | Buy | TABULA RASA HEALTHCARE INC | $10,208,000 | -4.9% | 209,689 | +7.3% | 1.30% | -19.5% |
| AMRN | Sell | AMARIN CORPORATION | $9,826,000 | -29.5% | 458,289 | -50.1% | 1.26% | -40.4% |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $8,583,000 | +23.0% | 101,510 | -2.0% | 1.10% | +4.0% |
| ARNA | Sell | ARENA PHARMACEUTICALS INC | $8,436,000 | -3.4% | 185,728 | -2.7% | 1.08% | -18.3% |
| RARE | Sell | ULTRAGENYX PHARMACEUTICAL INC | $7,450,000 | -3.1% | 174,437 | -2.9% | 0.95% | -18.1% |
| LHCG | Sell | LHC GROUP INC | $7,332,000 | +20.7% | 53,222 | -0.5% | 0.94% | +2.1% |
| TRUP | Sell | TRUPANION INC | $7,196,000 | +46.8% | 192,099 | -0.4% | 0.92% | +24.2% |
| TECH | Sell | BIO TECHNE CORP | $6,169,000 | +11.7% | 28,103 | -0.4% | 0.79% | -5.5% |
| VRTX | Sell | VERTEX PHARMACEUTICALS INC | $5,806,000 | +28.8% | 26,517 | -0.4% | 0.74% | +8.8% |
| KIDS | Sell | ORTHOPEDIATRICS CORP | $5,710,000 | +32.7% | 121,514 | -0.4% | 0.73% | +12.3% |
| BLUE | Buy | BLUEBIRD BIO INC | $5,668,000 | +231.3% | 64,587 | +246.5% | 0.72% | +179.5% |
| CSII | Sell | CARDIOVASCULAR SYSTEMS INC | $5,123,000 | +1.8% | 105,438 | -0.4% | 0.66% | -13.8% |
| EPZM | Sell | EPIZYME INC | $4,852,000 | +137.5% | 197,243 | -0.4% | 0.62% | +100.6% |
| ELGXQ | Buy | ENDOLOGIX INC | $4,558,000 | -59.6% | 2,885,081 | +1.4% | 0.58% | -65.8% |
| LGND | Sell | LIGAND PHARMACEUTICALS INC | $4,535,000 | -8.1% | 43,483 | -12.3% | 0.58% | -22.3% |
| QDEL | Sell | QUIDEL CORP | $4,062,000 | +21.8% | 54,143 | -0.4% | 0.52% | +3.0% |
| SLP | Sell | SIMULATIONS PLUS INC | $3,623,000 | -16.5% | 124,618 | -0.3% | 0.46% | -29.4% |
| ALXN | Sell | ALEXION PHARMACEUTICALS INC | $2,843,000 | +8.7% | 26,284 | -1.6% | 0.36% | -8.1% |
| IBB | ISHARES NASDAQ BIOTECHNOLOGY ETFetf | $2,561,000 | +21.1% | 21,248 | 0.0% | 0.33% | +2.2% | |
| PSCH | INVESCO SMALLCAP HEALTH CARE ETFetf | $2,234,000 | +13.9% | 17,285 | 0.0% | 0.29% | -3.4% | |
| IHI | ISHARES US MEDICAL DEVICES ETFetf | $2,004,000 | +6.9% | 7,580 | 0.0% | 0.26% | -9.5% | |
| XLV | HEALTH CARE SELECT SECTOR SPDR ETFetf | $1,858,000 | +13.0% | 18,241 | 0.0% | 0.24% | -4.8% | |
| LMAT | Sell | LEMAITRE VASCULAR INC | $1,749,000 | +4.4% | 48,642 | -0.7% | 0.22% | -11.5% |
| GBT | New | GLOBAL BLOOD THERAPEUTICS INC | $1,113,000 | – | 14,000 | +100.0% | 0.14% | – |
| TLGT | Sell | TELIGENT INC | $712,000 | -76.7% | 1,671,496 | -48.0% | 0.09% | -80.3% |
| BMY | Sell | BRISTOL MYERS SQUIBB CO | $655,000 | -88.8% | 10,200 | -91.2% | 0.08% | -90.5% |
| TMDX | TRANSMEDICS GROUP INC | $513,000 | -20.0% | 27,000 | 0.0% | 0.07% | -32.0% | |
| AGN | ALLERGAN PLC SHS | $412,000 | +13.5% | 2,157 | 0.0% | 0.05% | -3.6% | |
| HCAT | HEALTH CATALYST INC | $385,000 | +9.7% | 11,100 | 0.0% | 0.05% | -7.5% | |
| MRK | MERCK & CO INC | $386,000 | +7.8% | 4,247 | 0.0% | 0.05% | -9.3% | |
| ABBV | ABBVIE | $364,000 | +16.7% | 4,114 | 0.0% | 0.05% | 0.0% | |
| NVS | NOVARTIS AG-SPONSORED ADR | $335,000 | +9.1% | 3,535 | 0.0% | 0.04% | -6.5% | |
| SNY | SANOFI-SYNTHELABO | $334,000 | +8.4% | 6,650 | 0.0% | 0.04% | -8.5% | |
| PFE | PFIZER INC | $332,000 | +9.2% | 8,469 | 0.0% | 0.04% | -8.7% | |
| JNJ | JOHNSON AND JOHNSON | $315,000 | +12.5% | 2,161 | 0.0% | 0.04% | -4.8% | |
| BAX | BAXTER INTERNATIONAL INC | $272,000 | -4.6% | 3,258 | 0.0% | 0.04% | -18.6% | |
| AMGN | AMGEN INC | $263,000 | +24.6% | 1,092 | 0.0% | 0.03% | +6.2% | |
| STE | STERIS CORP | $251,000 | +5.5% | 1,649 | 0.0% | 0.03% | -11.1% | |
| HRC | HILL-ROM HOLDINGS INC | $241,000 | +8.1% | 2,121 | 0.0% | 0.03% | -8.8% | |
| ANTM | New | ANTHEM INC COM | $240,000 | – | 795 | +100.0% | 0.03% | – |
| GRFS | GRIFOLS SA SPONSORED ADR CLASS B | $237,000 | +16.2% | 10,166 | 0.0% | 0.03% | -3.2% | |
| A | New | AGILENT TECHNOLOGIES INC | $217,000 | – | 2,548 | +100.0% | 0.03% | – |
| SNN | SMITH & NEPHEW PLC SPONSORED ADR | $215,000 | 0.0% | 4,472 | 0.0% | 0.03% | -18.2% | |
| UNH | New | UNITEDHEALTH GROUP INC | $203,000 | – | 692 | +100.0% | 0.03% | – |
| BIO | New | BIO RAD LABS INC | $203,000 | – | 548 | +100.0% | 0.03% | – |
| DYNT | Buy | DYNATRONICS CORP | $105,000 | -13.9% | 126,044 | +3.9% | 0.01% | -27.8% |
| TXG | Exit | 10X GENOMICS INC CLASS A | $0 | – | -5,000 | -100.0% | -0.04% | – |
| NVTRQ | Exit | NUVECTRA CORP | $0 | – | -1,334,512 | -100.0% | -0.27% | – |
| ALKS | Exit | ALKERMES PLC | $0 | – | -123,107 | -100.0% | -0.36% | – |
| FIXX | Exit | HOMOLOGY MEDICINES INC. | $0 | – | -142,449 | -100.0% | -0.39% | – |
| ADRO | Exit | ADURO BIOTECH INC | $0 | – | -2,497,022 | -100.0% | -0.40% | – |
| TAK | Exit | TAKEDA PHARMACEUTICAL CO | $0 | – | -283,200 | -100.0% | -0.74% | – |
| AGIO | Exit | AGIOS PHARMACEUTICALS INC | $0 | – | -332,442 | -100.0% | -1.63% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ATRICURE INC | 40 | Q3 2023 | 9.7% |
| NEOGENOMICS INC | 40 | Q3 2023 | 10.6% |
| SANOFI-SYNTHELABO | 40 | Q3 2023 | 1.9% |
| JOHNSON & JOHNSON | 40 | Q3 2023 | 0.3% |
| PFIZER INC | 39 | Q2 2023 | 0.9% |
| BIOMARIN PHARMACEUTICAL INC | 36 | Q3 2023 | 1.6% |
| OMNICELL INC | 33 | Q3 2023 | 7.7% |
| QUIDEL CORP | 33 | Q4 2021 | 3.7% |
| NOVARTIS AG-SPONSORED ADR | 33 | Q3 2023 | 0.4% |
| MODEL N INC | 30 | Q3 2023 | 9.0% |
View First Light Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| REATA PHARMACEUTICALS INC | May 15, 2023 | 1,290,193 | 3.9% |
| Axogen, Inc. | February 03, 2023 | 1,942,270 | 4.6% |
| MODEL N, INC. | February 03, 2023 | 1,845,134 | 4.9% |
| MEI Pharma, Inc.Sold out | May 31, 2022 | 0 | 0.0% |
| PROTHENA CORP PUBLIC LTD CO | March 01, 2022 | 1,805,038 | 3.9% |
| Intersect ENT, Inc. | February 14, 2022 | 1,375,210 | 4.1% |
| SeaSpine Holdings Corp | February 14, 2022 | 6,847,707 | 18.8% |
| Oxford Immunotec Global PLCSold out | February 10, 2021 | 0 | 0.0% |
| ENDOLOGIX INC /DE/ | February 14, 2020 | 816,236 | 4.6% |
| Nuvectra CorpSold out | February 14, 2020 | 0 | 0.0% |
View First Light Asset Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-09 |
| 4 | 2024-04-08 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
View First Light Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.